Merck Sharp & Dohme Europe Belgium SRL

MSD is a member of , EFPIA, VE, EuropaBio, AmCham EU, Friends of Europe, EURORDIS, EAPM (European Alliance for personalised Medicine), CER (Centre for European Reform), EPC (European Policy Council), AECA (The American European Community Association), ACEBA (American-Central European Business Association), Press Club, European Internet Forum, Digital Europe, British Chamber of Commerce, Kangoroo Group, European Food Forum, European Risk and Innovation Forum, AnimalhealthEurope, European Forum of Farm Animal Breeders, EPAA (European Partnership for Alternative Approaches to Animal Testing), Lung Cancer Policy Network, Allied for Startups, All.Can International, EUCOPE

N/A

Promotes their own interests or the collective interests of their members

Jan 2023 - Dec 2023

1,250,000€ - 1,499,999€

None declared

1,250,000€ - 1,499,999€

The amount declared in answer includes: relevant percentage of trade associations' work and consultants as declared

None declared

Unofficial groupings

Working actively with several industry associations, eg. EFPIA, EUCOPE, EuropaBio, EAPM. Organizing events on industrial and health policy. Engaging with EU policy makers in EU institutions. Working actively with other health policy stakeholders.

None declared

16 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

• Date	23 Jan 2024	Location	Brussels
  Subject	Pharmaceutical
  Cabinet	Cabinet of Commissioner Mairead Mcguinness
  Attending	Patricia Reilly (Cabinet member)

• Date	02 Jun 2023	Location	Haarlem
  Subject	European Green Deal, European pharmaceutical strategy
  Cabinet	Cabinet of Executive Vice-President Frans Timmermans
  Portfolio	European Green Deal
  Attending	Diederik Samsom (Cabinet member)

• Date	07 Jun 2022	Location	videoconference
  Subject	MSD Italia shared their views regarding the pharma sector and the priorities and challenges they see, with respect to the need to support and preserve a competitive and innovative environment in the EU when it comes to medical treatments.
  Cabinet	Cabinet of Commissioner Paolo Gentiloni
  Portfolio	Economy
  Attending	Roberta Torre (Cabinet member)

• Date	15 May 2019	Location	Brussels
  Subject	Health research in Horizon Europe
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Giulia Del Brenna (Cabinet member)

• Date	30 Aug 2018	Location	Brussels
  Subject	Access to maternal healthcare, External Investment Plan
  Cabinet	Cabinet of Vice-President Neven Mimica
  Portfolio	International Cooperation & Development
  Attending	Nils Behrndt (Cabinet member)

• Date	28 Mar 2018	Location	Brussels
  Subject	IP and trade
  Cabinet	Cabinet of Vice-President Cecilia Malmström
  Portfolio	Trade
  Attending	Nele Eichhorn (Cabinet member)

• Date	20 Feb 2018	Location	Brussels
  Subject	State of play in discussions on beta agonist compounds within the Codex Alimentarius
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Arunas Ribokas (Cabinet member)

• Date	11 Oct 2017	Location	Brussels
  Subject	Antimicrobial Resistance
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Arunas Ribokas (Cabinet member)

• Date	09 Jun 2017	Location	Brussels
  Subject	Animal Health legislation
  Cabinet	Cabinet of First Vice-President Frans Timmermans
  Portfolio	Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
  Attending	Bernardus Smulders (Cabinet member)

• Date	17 Mar 2017	Location	Brussels
  Subject	AMR
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member) Arunas Ribokas (Cabinet member)

• Date	03 Mar 2017	Location	Brussels, BERL
  Subject	role of animal health in the agri-food chain; innovative approaches to livestock diseases and the judicious use of vaccines in farm animals; One Health agenda
  Cabinet	Cabinet of Commissioner Phil Hogan
  Portfolio	Agriculture & Rural Development
  Attending	Dermot Ryan (Cabinet member)

• Date	21 Oct 2016	Location	Brussels
  Subject	Commission's health priorities
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Arunas Ribokas (Cabinet member) Vytenis Andriukaitis (Commissioner)

• Date	25 May 2016	Location	Brussels
  Subject	Developing treatments eg. on Hepatitis C and Azlheimer's and improving availability of medicines
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member) Paula Duarte Gaspar (Cabinet member)

• Date	14 Jan 2016	Location	Brussels
  Subject	AECA Round-Table on “Dealing with Regulatory Burden
  Cabinet	Cabinet of First Vice-President Frans Timmermans
  Portfolio	Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
  Attending	Bernardus Smulders (Cabinet member)
  Other Lobbyists	Procter & Gamble

• Date	13 Oct 2015	Location	Brussels
  Subject	AMR
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Paula Duarte Gaspar (Cabinet member) Arunas Ribokas (Cabinet member)
  Other Lobbyists	Covington & Burling LLP

• Date	18 May 2015	Location	Brussels
  Subject	Role of Pharma industries in R& I
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Carlos Moedas (Commissioner)